GenomeRunner statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Regulatory variant prediction chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

GenomeRunner specifications


Unique identifier OMICS_11439
Name GenomeRunner
Interface Web user interface
Restrictions to use None
Programming languages Python
Computer skills Basic
Stability Stable
Maintained Yes


  • person_outline Mikhail G. Dozmorov <>

Publications for GenomeRunner

GenomeRunner in publications

PMCID: 5676057
PMID: 28948711
DOI: 10.1111/acel.12681

[…] of sex‐common and sex‐divergent differences with aging., enrichment of admcgs in enhancer regions was also performed against encode datasets of mouse brain tissue enhancer locations using genomerunner (dozmorov et al., ) (fig. c,d). regions associated with active transcription, h3k4me3, h3k27ac, and polii, were generally under‐represented as a location for admcgs, regardless […]

PMCID: 5390918
PMID: 28469415
DOI: 10.1177/1177932216687545

[…] and statistical methods for the integrative analysis of “omics” data and focuses on precision medicine approaches. he has developed a bioinformatics program and a biostatistics approach, genomerunner (, to automate genome and epigenome exploration. he uses functional epigenomic data from the encode and roadmap epigenomics projects to understand […]

PMCID: 5011241
PMID: 27635400
DOI: 10.1155/2016/8642703

[…] diseases []), or after treatment [], as we predicted [] on the basis of the central limit theorem., as an unexpected clever generalization of this mainstream approach, the authors of web server genomerunner [] proposed to evaluate the difference between snps in addition to the widely accepted notion of assessments of the similarity between them. in this active field of research, the new […]

PMCID: 4848848
PMID: 27127542
DOI: 10.1186/s13148-016-0212-7

[…] [] (fig. ). given the large volumes of genome annotation data, the regulatory enrichment analysis methods are less well developed than functional enrichment analysis methods. however, tools like genomerunner [], enrichr [], and goshifter [] have been successfully applied to the interpretation of dmrs identified with 450k technology in studies of autoimmunity [, ] and aging [, ]. […]

PMCID: 4699364
PMID: 26699738
DOI: 10.1186/s13059-015-0842-7

[…] non-permuted data. the permutation p values were then calculated from the corresponding z-scores., in the phase 2 bioinformatics analyses, we used a database of genomic annotations assembled in the genomerunner project [] to examine enrichment of meqtls in selected annotation classes. these included (1) individual disease-associated snp sets from the manually curated nhgri catalog of published […]

To access a full list of publications, you will need to upgrade to our premium service.

GenomeRunner institution(s)
Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA; Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Okla-homa City, OK, USA; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Cen-ter, Oklahoma City, OK, USA
GenomeRunner funding source(s)
This work was supported by the Virginia Commonwealth University start-up fund, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (a subaward from grant # P30 AR053483), an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (a subaward from grant # P30 GM103510), and the National Science Foundation (Grant # ACI-1345426) for partial funding of this work.

GenomeRunner reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review GenomeRunner